Håkan Emanuelsson - Concepedia

Author

Håkan Emanuelsson

Also Known As

Emanuelsson, Håkan, H Emanuelsson, Håkan Emanuelsson, H. EMANUELSSON, H. Emanuelsson, Hakan Emanuelsson, Håkan Emanuelsson, HÄKAN EMANUELSSON, HÅKAN EMANUELSSON, HÅKan Emanuelsson

135

Publications

22.9K

Citations

H-Index

Concepts

All Affiliations

Sahlgrenska University Hospital AstraZeneca (Sweden)University of Sheffield Aarhus University Hospital Brigham and Women's Hospital

About

Håkan Emanuelsson is an author at Sahlgrenska University Hospital specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	50	6.4K
2	Public Health	14	15	2.8K
3	Health Sciences	2	2	260
4	Social Sciences	2	2	103
5	Engineering	1	1	16

Håkan Emanuelsson

Publications

22.8K

Citations

H-Index

Page 1

	Year	Citations
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes Lars Wallentin, Richard C. Becker, Andrzej Budaj, New England Journal of Medicine	2009	7K
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease Patrick W. Serruys, Peter de Jaegere, Ferdinand Kiemeneij, New England Journal of Medicine	1994	4.5K
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin Steen Husted, Håkan Emanuelsson, Stan Heptinstall, European Heart Journal	2006	738
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Christopher P. Cannon, Robert A. Harrington, Stefan James, The Lancet ThrombosisRandomised Double-blind StudyCardiovascular DiseaseMedicineCoronary Artery Disease	2010	658
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Patrick W Serruys, Ben van Hout, Hans Bonnier, The Lancet Percutaneous Coronary InterventionEndovascular TechniqueCardiovascular DiseaseAtherosclerosisHeparin-coated Stents	1998	655
Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention Philippe Gabríel Steg, Stefan James, Robert A. Harrington, Circulation	2010	502
Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Christopher P. Cannon, Steen Husted, Robert A. Harrington, Journal of the American College of Cardiology Molecular PharmacologyThrombosisCardiovascular DiseaseInitial EfficacyCoronary Artery Disease	2007	490
Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes Robert F. Storey, Steen Husted, Robert A. Harrington, Journal of the American College of Cardiology ThrombopoiesisThrombosisPlatelet Aggregation InhibitorsCardiovascular DiseaseBlood Platelet	2007	484
Randomized Evaluation of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation in High-Risk Patients Philip Urban, Carlos Macaya, Hans‐Jürgen Rupprecht, Circulation	1998	444
Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries Patrick W. Serruys, Håkan Emanuelsson, Wim van der Giessen, Circulation	1996	404

Page 1